Live Breaking News & Updates on Longboard Pharmaceuticals Stock Performance

Stay updated with breaking news from Longboard pharmaceuticals stock performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Parkman Healthcare Partners LLC Buys 73,935 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)

Parkman Healthcare Partners LLC increased its stake in shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) by 20.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 429,892 shares of the company’s stock after buying an additional 73,935 shares during […] ....

Longboard-pharmaceuticals-inc , News-ratings-for-longboard-pharmaceuticals-daily , Jennison-associates , Longboard-pharmaceuticals-stock-performance , Quarter-for-longboard-pharmaceuticals , Asset-management-inc , Nasdaq , Exchange-commission , Longboard-pharmaceuticals , Citigroup , Cantor-fitzgerald

Longboard Pharmaceuticals' (LBPH) "Buy" Rating Reiterated at HC Wainwright

Longboard Pharmaceuticals' (LBPH) "Buy" Rating Reiterated at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird , Bourgeon-capital-management , Longboard-pharmaceuticals , Td-asset-management-inc , Citigroup , Longboard-pharmaceuticals-stock-performance , Denali-advisors , News-ratings-for-longboard-pharmaceuticals-daily , Analyst-recommendations-for-longboard-pharmaceuticals , Cantor-fitzgerald , Sg-americas-securities

Cantor Fitzgerald Reiterates "Overweight" Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Cantor Fitzgerald in a research note issued on Friday, Benzinga reports. They currently have a $60.00 target price on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 178.68% from the company’s current price. Other […] ....

Robertw-baird , Longboard-pharmaceuticals-stock-performance , Longboard-pharmaceuticals , Parkman-healthcare-partners , Longboard-pharmaceuticals-company-profile , Td-asset-management-inc , Cantor-fitzgerald , Analyst-recommendations-for-longboard-pharmaceuticals , Bourgeon-capital-management , News-ratings-for-longboard-pharmaceuticals-daily , Denali-advisors

Cantor Fitzgerald Reiterates "Overweight" Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “overweight” rating reissued by stock analysts at Cantor Fitzgerald in a research note issued to investors on Friday, Benzinga reports. They currently have a $60.00 price target on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 178.68% from the stock’s current […] ....

Robertw-baird , Longboard-pharmaceuticals-company-profile , Td-asset-management-inc , Cantor-fitzgerald , Longboard-pharmaceuticals-stock-performance , Parkman-healthcare-partners , Longboard-pharmaceuticals , Jennison-associates , News-ratings-for-longboard-pharmaceuticals-daily , Longboard-pharmaceuticals-inc , Citigroup

Cantor Fitzgerald Reiterates "Overweight" Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “overweight” rating reissued by stock analysts at Cantor Fitzgerald in a research note issued to investors on Friday, Benzinga reports. They currently have a $60.00 price target on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 178.68% from the stock’s current […] ....

Robertw-baird , Longboard-pharmaceuticals-stock-performance , Parkman-healthcare-partners , Longboard-pharmaceuticals , Jennison-associates , Longboard-pharmaceuticals-company-profile , Td-asset-management-inc , Cantor-fitzgerald , Platinum-investment-management-ltd , Analyst-recommendations-for-longboard-pharmaceuticals , News-ratings-for-longboard-pharmaceuticals-daily